|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net Income | |||||
| Adjustment to reconcile net income to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Asset Impairments | |||||
| Goodwill impairment | |||||
| Amortization of debt issuance costs and accretion of debt discount | |||||
| Non-cash lease expense | |||||
| Equity based compensation expense | |||||
| Equity based payments to third parties | |||||
| Gain on sale of business | |||||
| Change in fair value of digital assets (unrealized loss) | |||||
| Recognition and change in fair value of warrant liability | |||||
| Earn-out fair value and write-off adjustments | |||||
| Change in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Accounts receivable, related parties | |||||
| Other receivables | |||||
| Prepaid expense and other current assets | |||||
| Other non-current assets | |||||
| Accounts payables and other accrued liabilities | |||||
| Other payables | |||||
| Net cash used in continuing operating activities | |||||
| Net cash adjustments for discontinued operating activities | |||||
| Net cash used in operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Proceeds from sale of investment in NSURE | |||||
| Net cash provided and used in continuing investing activities | |||||
| Purchase of property and equipment | |||||
| Purchase of intangibles | |||||
| Sale of business, net of cash sold | |||||
| Sales of digital assets | |||||
| Purchases of digital assets | |||||
| Net cash provided from (used in) investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Principal repayments of debt | |||||
| Proceeds from short term financings | |||||
| Principal repayments of short term financings | |||||
| Proceeds from loans payable, related parties | |||||
| Payments of loans payable, related parties | |||||
| Cash payments and proceeds of convertible debt, related parties | |||||
| Payments of earn-out liabilities | |||||
| Proceeds from exercise of warrants into common stock | |||||
| Payments of convertible debt, related parties | |||||
| Proceeds from common shares issued through an at the market offering | |||||
| Proceeds from common shares issued through an equity line of credit | |||||
| Private Placement of shares and warrants | |||||
| Net cash provided by continuing financing activities | |||||
| Net cash used in discontinued financing activities | |||||
| Cash dividends paid | |||||
| Net cash (used in) provided by financing activities | |||||
| Net increase in cash and restricted cash | |||||
| Cash and restricted cash at beginning of year | |||||
| Cash and restricted cash at end of year | |||||
| SUPPLEMENTAL DISCLOSURE OF CASH AND NON-CASH TRANSACTIONS: | |||||
| Cash paid for interest | |||||
| Noncash investing and financing transactions: | |||||
| Common shares issued to settle convertible debt, related parties | |||||
| Common shares issued for earnout liabilities | |||||
| Common shares issued for Series B warrants | |||||
| Common stock issued for pre-paid assets | |||||
| Common shares issued for an acquisition prepayment | |||||
| Lease assets acquired in exchange for lease liabilities | |||||
Loading...